eREX Co.,Ltd. (9517.T)
Tokyo, JP
eREX Co.,Ltd. is a Japanese energy company that specializes in the production and distribution of electricity. The firm operates a power generation facility that utilizes biomass. In addition to its energy generation activities, eREX also actively participates in the electricity trading market. Established in 1999, the company's main office is situated in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.23% | -7.16% | -0.40% | +50.08% | +48.72% | +62.17% | +18.23% | -28.08% | -46.82% | +61.55% | +84.76% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Renewable Utilities: +1.3%-1.2% Q1'26: -7.7% (vs Q1'25)
-
EPS growth Renewable Utilities: +6.7%+138.6% ★ Q1'26: +169.4% (vs Q1'25)
-
FCF margin FCF growth · Renewable Utilities: +50.4%+2.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Renewable Utilities: +22.3%+4.4% Q1'26: +7.0% (vs Q1'25)
-
ROIC Renewable Utilities: +3.5%— Q1'26: +6.8% (vs Q1'25)
-
Share dilution Renewable Utilities: +0.0%+5.5% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Renewable Utilities: 3.24×— Q1'26: 4.16× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 2 EPS Ana. |
Mar 2027 3 Rev. Ana. 3 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
17.07B
est: 17.00B (+0.4%)
|
22.88B
est: 22.65B (+1.0%)
|
31.17B
est: 31.40B (-0.7%)
|
46.95B
est: 45.72B (+2.7%)
|
65.83B
est: 66.20B (-0.6%)
|
88.64B
est: 91.53B (-3.2%)
|
141.89B
est: 128.46B (+10.5%)
|
230.50B
est: 218.43B (+5.5%)
|
296.31B
est: 293.00B (+1.1%)
|
244.98B
est: 222.52B (+10.1%)
|
171.22B
est: 172.08B (-0.5%)
|
169.88B
158.65B – 179.00B
-1.3% YoY
|
176.33B
150.98B – 203.00B
+3.8% YoY
|
176.68B
155.38B – 195.77B
+0.2% YoY
|
166.64B
144.62B – 188.23B
-5.7% YoY
|
167.45B
145.33B – 189.15B
+0.5% YoY
|
| EBITDA |
1.98B
est: 967.20M (+104.8%)
|
2.18B
est: 1.29B (+69.2%)
|
4.40B
est: 1.79B (+146.5%)
|
6.47B
est: 2.60B (+148.8%)
|
6.39B
est: 3.77B (+69.5%)
|
11.55B
est: 5.21B (+121.8%)
|
19.72B
est: 7.31B (+169.8%)
|
17.63B
est: 12.43B (+41.9%)
|
20.73B
est: 16.67B (+24.4%)
|
-14.84B
est: 13.45B (-210.4%)
|
13.25B
est: 10.40B (+27.4%)
|
10.27B
9.59B – 10.82B
-1.3% YoY
|
10.66B
9.13B – 12.27B
+3.8% YoY
|
10.68B
9.39B – 11.83B
+0.2% YoY
|
10.07B
8.74B – 11.38B
-5.7% YoY
|
10.12B
8.78B – 11.43B
+0.5% YoY
|
| EBIT |
1.48B
est: 601.29M (+145.4%)
|
1.72B
est: 801.13M (+115.1%)
|
3.54B
est: 1.11B (+218.3%)
|
4.82B
est: 1.62B (+197.8%)
|
4.70B
est: 2.34B (+100.9%)
|
9.25B
est: 3.24B (+185.6%)
|
15.72B
est: 4.54B (+246.0%)
|
12.50B
est: 7.73B (+61.8%)
|
14.82B
est: 10.36B (+43.0%)
|
-18.97B
est: 8.60B (-320.5%)
|
9.54B
est: 6.65B (+43.4%)
|
6.57B
6.13B – 6.92B
-1.3% YoY
|
6.82B
5.84B – 7.85B
+3.8% YoY
|
6.83B
6.01B – 7.57B
+0.2% YoY
|
6.44B
5.59B – 7.28B
-5.7% YoY
|
6.47B
5.62B – 7.31B
+0.5% YoY
|
| Net Income |
922.91M
est: 2.20B (-58.0%)
|
1.11B
est: 1.64B (-32.1%)
|
1.92B
est: 3.00B (-36.1%)
|
3.04B
est: 4.22B (-27.9%)
|
2.76B
est: 3.79B (-27.0%)
|
4.52B
est: 6.80B (-33.5%)
|
6.29B
est: 7.76B (-19.0%)
|
9.65B
est: 10.86B (-11.1%)
|
9.13B
est: 9.58B (-4.7%)
|
-21.35B
est: -16.71B (-27.7%)
|
2.12B
est: 2.33B (-8.9%)
|
3.94B
3.32B – 4.57B
+69.5% YoY
|
4.41B
3.79B – 4.93B
+11.8% YoY
|
4.71B
4.39B – 5.17B
+6.8% YoY
|
5.35B
4.43B – 6.25B
+13.6% YoY
|
5.43B
4.49B – 6.34B
+1.5% YoY
|
| SGA |
1.20B
est: 853.71M (+40.7%)
|
2.01B
est: 1.14B (+76.4%)
|
3.39B
est: 1.58B (+115.1%)
|
4.55B
est: 2.30B (+98.2%)
|
5.43B
est: 3.32B (+63.4%)
|
6.41B
est: 4.60B (+39.5%)
|
8.81B
est: 6.45B (+36.5%)
|
10.07B
est: 10.97B (-8.2%)
|
10.75B
est: 14.71B (-26.9%)
|
8.98B
est: 10.48B (-14.4%)
|
9.75B
est: 8.11B (+20.2%)
|
8.00B
7.48B – 8.43B
-1.3% YoY
|
8.31B
7.11B – 9.56B
+3.8% YoY
|
8.32B
7.32B – 9.22B
+0.2% YoY
|
7.85B
6.81B – 8.87B
-5.7% YoY
|
7.89B
6.85B – 8.91B
+0.5% YoY
|
| EPS |
29.78
est: 29.70 (+0.3%)
|
26.78
est: 22.17 (+20.8%)
|
38.40
est: 40.59 (-5.4%)
|
60.30
est: 57.03 (+5.7%)
|
54.63
est: 51.23 (+6.6%)
|
89.01
est: 91.92 (-3.2%)
|
116.28
est: 104.90 (+10.8%)
|
163.44
est: 146.83 (+11.3%)
|
154.28
est: 131.75 (+17.1%)
|
-359.94
est: -270.36 (-33.1%)
|
28.65
est: 31.51 (-9.1%)
|
53.32
44.86 – 61.79
+69.2% YoY
|
57.46
51.30 – 66.67
+7.8% YoY
|
63.18
59.42 – 69.98
+10.0% YoY
|
72.30
59.88 – 84.48
+14.4% YoY
|
73.40
60.80 – 85.77
+1.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 1/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 1/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-01 | B- | 3/5 | 1/5 | 1/5 | 3/5 | 3/5 | 2/5 | 5/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 1/5 | 3/5 | 3/5 | 2/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 3/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 1/5 | 4/5 | 2/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.04% | 143.2K | 0.58% |
| 2 | State Street SPDR S&P International Small Cap ETF GWX | 0.02% | 147.7K | 0.40% |
| 3 | Schwab International Small-Cap Equity ETF SCHC | 0.01% | 286.5K | 0.06% |
| 4 | Avantis International Small Cap Value ETF AVDV | 0.00% | 838.3K | 0.36% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 629.7K | 0.06% |
| 6 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 13.7K | 0.30% |
| 7 | iShares Core TOPIX ETF 1475.T | 0.00% | 511.4K | 0.05% |
| 8 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.00% | 30.1K | 0.39% |
| 9 | State Street SPDR Portfolio Developed World ex-US ETF SPDW | 0.00% | 1.04M | 0.03% |
| 10 | Avantis International Equity ETF AVDE | 0.00% | 209.2K | 0.23% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hitoshi Honna | President & Representative Director | 147M | male |
| Tomoki Tsunoda | MD & Director | — | male |
| Toshimichi Tanaka | MD, GM of the Supply & Demand Strategy Office & Director | — | male |
| Yasushi Saito | MD, Director & Human Resources Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 9517.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
